Since elevated circulating levels of KL-6 indicate disruption of the alveolar epithelial lining, we hypothesized that it could be advantageous analysing KL-6/MUC1 in a group of severe COVID-19-positive patients, to better risk stratify and triage them. Here, MUC1 is linked to COVID-19.